Zhejiang CONBA Pharmaceutical Co.,Ltd. (600572.SS)
CNY 4.77
(0.0%)
CNY 4.77
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 11.23 Billion CNY | 2.82% |
| 2022 | 10.92 Billion CNY | 1.27% |
| 2021 | 10.79 Billion CNY | 16.32% |
| 2020 | 9.27 Billion CNY | -5.9% |
| 2019 | 9.86 Billion CNY | -7.96% |
| 2018 | 10.71 Billion CNY | 13.73% |
| 2017 | 9.42 Billion CNY | 10.89% |
| 2016 | 8.49 Billion CNY | -11.22% |
| 2015 | 9.56 Billion CNY | 51.91% |
| 2014 | 6.29 Billion CNY | 41.43% |
| 2013 | 4.45 Billion CNY | -1.87% |
| 2012 | 4.53 Billion CNY | 53.31% |
| 2011 | 2.96 Billion CNY | 20.17% |
| 2010 | 2.46 Billion CNY | 27.76% |
| 2009 | 1.92 Billion CNY | 22.87% |
| 2008 | 1.56 Billion CNY | 1.37% |
| 2007 | 1.54 Billion CNY | 23.27% |
| 2006 | 1.25 Billion CNY | 8.67% |
| 2005 | 1.15 Billion CNY | 17.75% |
| 2004 | 981.41 Million CNY | 68.73% |
| 2003 | 581.65 Million CNY | 25.73% |
| 2002 | 462.62 Million CNY | 3.35% |
| 2001 | 447.63 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 9.74 Billion CNY | -4.93% |
| 2024 Q2 | 10.25 Billion CNY | -9.34% |
| 2024 Q1 | 11.31 Billion CNY | 0.64% |
| 2023 Q1 | 11.77 Billion CNY | 7.72% |
| 2023 Q2 | 11.48 Billion CNY | -2.43% |
| 2023 Q3 | 11.16 Billion CNY | -2.83% |
| 2023 Q4 | 11.23 Billion CNY | 0.68% |
| 2023 FY | 11.23 Billion CNY | 2.82% |
| 2022 Q2 | 10.64 Billion CNY | -5.7% |
| 2022 Q4 | 10.92 Billion CNY | 2.73% |
| 2022 FY | 10.92 Billion CNY | 1.27% |
| 2022 Q1 | 11.28 Billion CNY | 4.59% |
| 2022 Q3 | 10.63 Billion CNY | -0.05% |
| 2021 Q3 | 8.88 Billion CNY | -2.41% |
| 2021 Q2 | 9.1 Billion CNY | 2.12% |
| 2021 Q1 | 8.91 Billion CNY | -3.88% |
| 2021 FY | 10.79 Billion CNY | 16.32% |
| 2021 Q4 | 10.79 Billion CNY | 21.43% |
| 2020 Q4 | 9.27 Billion CNY | -6.89% |
| 2020 Q1 | 10.18 Billion CNY | 3.26% |
| 2020 Q3 | 9.96 Billion CNY | -1.0% |
| 2020 Q2 | 10.06 Billion CNY | -1.14% |
| 2020 FY | 9.27 Billion CNY | -5.9% |
| 2019 Q4 | 9.86 Billion CNY | -8.49% |
| 2019 Q2 | 10.99 Billion CNY | 0.64% |
| 2019 Q1 | 10.92 Billion CNY | 1.94% |
| 2019 FY | 9.86 Billion CNY | -7.96% |
| 2019 Q3 | 10.77 Billion CNY | -1.97% |
| 2018 Q3 | 10.94 Billion CNY | 4.95% |
| 2018 Q4 | 10.71 Billion CNY | -2.15% |
| 2018 Q2 | 10.43 Billion CNY | 8.94% |
| 2018 Q1 | 9.57 Billion CNY | 1.65% |
| 2018 FY | 10.71 Billion CNY | 13.73% |
| 2017 Q1 | 8.4 Billion CNY | -1.07% |
| 2017 FY | 9.42 Billion CNY | 10.89% |
| 2017 Q2 | 8.17 Billion CNY | -2.74% |
| 2017 Q3 | 8.25 Billion CNY | 0.95% |
| 2017 Q4 | 9.42 Billion CNY | 14.16% |
| 2016 FY | 8.49 Billion CNY | -11.22% |
| 2016 Q2 | 8.8 Billion CNY | -10.07% |
| 2016 Q1 | 9.79 Billion CNY | 2.37% |
| 2016 Q3 | 10.24 Billion CNY | 16.26% |
| 2016 Q4 | 8.49 Billion CNY | -17.05% |
| 2015 Q2 | 9.51 Billion CNY | 47.74% |
| 2015 Q4 | 9.56 Billion CNY | 1.39% |
| 2015 Q3 | 9.43 Billion CNY | -0.86% |
| 2015 FY | 9.56 Billion CNY | 51.91% |
| 2015 Q1 | 6.44 Billion CNY | 2.29% |
| 2014 FY | 6.29 Billion CNY | 41.43% |
| 2014 Q1 | 4.67 Billion CNY | 4.93% |
| 2014 Q2 | 5.84 Billion CNY | 25.12% |
| 2014 Q3 | 5.91 Billion CNY | 1.24% |
| 2014 Q4 | 6.29 Billion CNY | 6.4% |
| 2013 Q4 | 4.45 Billion CNY | 3.1% |
| 2013 FY | 4.45 Billion CNY | -1.87% |
| 2013 Q3 | 4.32 Billion CNY | 2.66% |
| 2013 Q2 | 4.2 Billion CNY | -4.52% |
| 2013 Q1 | 4.4 Billion CNY | -2.89% |
| 2012 Q4 | 4.53 Billion CNY | 31.74% |
| 2012 Q3 | 3.44 Billion CNY | 12.51% |
| 2012 Q2 | 3.06 Billion CNY | -0.58% |
| 2012 FY | 4.53 Billion CNY | 53.31% |
| 2012 Q1 | 3.07 Billion CNY | 4.04% |
| 2011 Q4 | 2.96 Billion CNY | -4.52% |
| 2011 Q1 | 2.64 Billion CNY | 7.57% |
| 2011 Q2 | 3.13 Billion CNY | 18.16% |
| 2011 Q3 | 3.1 Billion CNY | -0.98% |
| 2011 FY | 2.96 Billion CNY | 20.17% |
| 2010 Q2 | 2.02 Billion CNY | 1.58% |
| 2010 FY | 2.46 Billion CNY | 27.76% |
| 2010 Q3 | 2.03 Billion CNY | 0.73% |
| 2010 Q1 | 1.99 Billion CNY | 3.36% |
| 2010 Q4 | 2.46 Billion CNY | 20.8% |
| 2009 Q1 | 1.59 Billion CNY | 1.57% |
| 2009 FY | 1.92 Billion CNY | 22.87% |
| 2009 Q4 | 1.92 Billion CNY | -1.71% |
| 2009 Q3 | 1.96 Billion CNY | 24.22% |
| 2009 Q2 | 1.57 Billion CNY | -0.92% |
| 2008 Q4 | 1.56 Billion CNY | 2.91% |
| 2008 FY | 1.56 Billion CNY | 1.37% |
| 2008 Q3 | 1.52 Billion CNY | -1.6% |
| 2008 Q2 | 1.54 Billion CNY | -1.19% |
| 2008 Q1 | 1.56 Billion CNY | 1.31% |
| 2007 Q2 | 1.28 Billion CNY | -2.47% |
| 2007 Q3 | 1.8 Billion CNY | 40.8% |
| 2007 FY | 1.54 Billion CNY | 23.27% |
| 2007 Q4 | 1.54 Billion CNY | -14.23% |
| 2007 Q1 | 1.31 Billion CNY | 4.65% |
| 2006 Q1 | 1.18 Billion CNY | 2.85% |
| 2006 Q3 | 1.22 Billion CNY | 5.85% |
| 2006 Q4 | 1.25 Billion CNY | 2.31% |
| 2006 FY | 1.25 Billion CNY | 8.67% |
| 2006 Q2 | 1.15 Billion CNY | -2.44% |
| 2005 FY | 1.15 Billion CNY | 17.75% |
| 2005 Q4 | 1.15 Billion CNY | 9.81% |
| 2005 Q3 | 1.05 Billion CNY | 2.25% |
| 2005 Q1 | 1.03 Billion CNY | 5.73% |
| 2005 Q2 | 1.02 Billion CNY | -0.82% |
| 2004 Q2 | 1 Billion CNY | 75.96% |
| 2004 Q1 | 569.86 Million CNY | -2.03% |
| 2004 FY | 981.41 Million CNY | 68.73% |
| 2004 Q4 | 981.41 Million CNY | -0.14% |
| 2004 Q3 | 982.77 Million CNY | -1.99% |
| 2003 Q4 | 581.65 Million CNY | 0.0% |
| 2003 FY | 581.65 Million CNY | 25.73% |
| 2002 FY | 462.62 Million CNY | 3.35% |
| 2001 FY | 447.63 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 43.78 Billion CNY | 74.333% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 17.08 Billion CNY | 34.204% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 3.27 Billion CNY | -242.699% |
| Aurora Optoelectronics Co.,Ltd. | 2.17 Billion CNY | -416.957% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 346.28 Million CNY | -3145.34% |
| NanJing Pharmaceutical Company Limited | 28.5 Billion CNY | 60.581% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 2.62 Billion CNY | -327.567% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 7.77 Billion CNY | -44.611% |